CATX · Perspective Therapeutics, Inc.
$3.23
+0.03 (+0.78%)
At close · Aug 17
Market Cap
$370.99M
Shares
114.15M
Perspective Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Perspective Therapeutics, Inc. (CATX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲15.9%
$2.21M
−$897,000
'19 Q4
20-02-11
▲49.7%
$2.88M
−$545,000
'20 Q1
20-05-12
▲18.5%
$2.28M
−$1.19M
'20 Q2
20-09-17
▲3%
$2.38M
−$713,000
'20 Q3
20-11-10
▲6.9%
$2.36M
−$868,000
'20 Q4
21-02-03
▼9.7%
$2.60M
−$745,000
'21 Q1
21-05-13
▲18.9%
$2.71M
−$1.06M
'21 Q2
21-09-21
▲7.6%
$2.56M
−$2.24M
'21 Q3
21-11-10
▲19.4%
$2.82M
−$1.60M
'21 Q4
22-02-08
▲11.9%
$2.91M
−$1.35M
'22 Q1
22-05-10
▼7.6%
$2.50M
−$2.08M
'22 Q2
22-09-28
LATEST
▼33%
$1.72M
−$4.07M
'22 Q3
22-11-10
Earnings call
FY24 · Q4
2025-01-13
Perspective Therapeutics, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Perspective Therapeutics, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-11-10
Perspective Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$1.72M
▼ 33% YoY Gross margin
24.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-09-28
Perspective Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$2.50M
▼ 7.6% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Perspective Therapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$2.91M
▲ 11.9% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Perspective Therapeutics, Inc. Q4 FY2021 Earnings Call
Revenue
$2.82M
▲ 19.4% YoY Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Perspective Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$2.56M
▲ 7.6% YoY Gross margin
40.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-09-21
Perspective Therapeutics, Inc. Q2 FY2021 Earnings Call
Revenue
$2.71M
▲ 18.9% YoY Gross margin
49.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Perspective Therapeutics, Inc. Q1 FY2021 Earnings Call
Revenue
$2.60M
▼ 9.7% YoY Gross margin
52.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-03
Perspective Therapeutics, Inc. Q4 FY2020 Earnings Call
Revenue
$2.36M
▲ 6.9% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Perspective Therapeutics, Inc. Q3 FY2020 Earnings Call
Revenue
$2.38M
▲ 3% YoY Gross margin
52.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-17
Perspective Therapeutics, Inc. Q2 FY2020 Earnings Call
Revenue
$2.28M
▲ 18.5% YoY Gross margin
47.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Perspective Therapeutics, Inc. Q1 FY2020 Earnings Call
Revenue
$2.88M
▲ 49.7% YoY Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-11
Perspective Therapeutics, Inc. Q4 FY2019 Earnings Call
Revenue
$2.21M
▲ 15.9% YoY Gross margin
50.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–14 of 14 earnings calls
Key facts
CIK
728387
CUSIP
46489V302
13F (30d)
126 filings
122 filers
Visit website
Investor relations